The overexpression of cyclin D1 in human cancers can result from genetic alterations, changes in epigenetic regulation, gene transcription, and protein translation of CCND1. We have shown that cyclin D1 is consistently overexpressed in PTC, and cyclin D1 immunostaining is useful for identifying the extent of tumor involvement [11]. This evidence concerns the gene CCND1 and neoplasm.